Conduit Holdings Limited

BST:CHO Stock Report

Market Cap: €901.4m

Conduit Holdings Valuation

Is CHO undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of CHO when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate CHO's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate CHO's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for CHO?

Key metric: As CHO is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for CHO. This is calculated by dividing CHO's market cap by their current earnings.
What is CHO's PE Ratio?
PE Ratio4.5x
EarningsUS$210.30m
Market CapUS$948.92m

Price to Earnings Ratio vs Peers

How does CHO's PE Ratio compare to its peers?

The above table shows the PE ratio for CHO vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average12.7x
HNR1 Hannover Rück
12.8x5.7%€28.9b
NBG6 NÜRNBERGER Beteiligungs-AG
14.4x38.4%€587.5m
MUV2 Münchener Rückversicherungs-Gesellschaft in München
11x2.9%€62.6b
RLV RheinLand Holding
12.5xn/a€112.9m
CHO Conduit Holdings
4.5x10.8%€752.7m

Price-To-Earnings vs Peers: CHO is good value based on its Price-To-Earnings Ratio (4.5x) compared to the peer average (12.5x).

Price to Earnings Ratio vs Industry

How does CHO's PE Ratio compare vs other companies in the European Insurance Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
CHO 4.5xIndustry Avg. 11.8xNo. of Companies13PE0816243240+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: CHO is good value based on its Price-To-Earnings Ratio (4.5x) compared to the European Insurance industry average (11.8x).

Price to Earnings Ratio vs Fair Ratio

What is CHO's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CHO PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio4.5x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate CHO's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst CHO forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Currentn/a
€7.83
0%
6.9%€8.62€6.94n/a5
Nov ’25n/a
€8.07
0%
4.6%€8.45€7.40n/a5
Oct ’25n/a
€7.90
0%
4.4%€8.34€7.30n/a5
Sep ’25n/a
€8.05
0%
4.5%€8.54€7.47n/a5
Aug ’25n/a
€8.05
0%
4.5%€8.54€7.47n/a5
Jul ’25n/a
€8.00
0%
4.2%€8.38€7.41n/a5
Jun ’25n/a
€7.73
0%
6.3%€8.28€6.99n/a5
May ’25n/a
€7.74
0%
6.3%€8.39€7.07n/a5
Apr ’25n/a
€7.67
0%
6.2%€8.30€7.00n/a5
Mar ’25€5.95
€7.68
+29.0%
6.3%€8.31€7.00n/a5
Feb ’25€5.35
€7.33
+37.0%
6.4%€8.16€6.76n/a5
Jan ’25€5.25
€7.08
+34.8%
7.7%€8.01€6.34n/a5
Dec ’24€5.30
€7.08
+33.5%
7.7%€8.01€6.34n/a5
Nov ’24€4.80
€7.03
+46.5%
5.3%€7.43€6.35n/a5
Oct ’24€5.10
€7.04
+38.1%
3.4%€7.36€6.67n/a5
Sep ’24€5.25
€6.90
+31.4%
4.2%€7.24€6.48n/a5
Aug ’24€5.40
€7.10
+31.5%
5.4%€7.66€6.48n/a5
Jul ’24€5.25
€6.82
+30.0%
6.4%€7.45€6.09n/a5
Jun ’24€5.60
€6.56
+17.2%
13.1%€7.53€4.87n/a6
May ’24€5.40
€6.36
+17.7%
11.8%€7.21€4.84n/a6
Apr ’24€5.90
€6.36
+7.7%
11.8%€7.21€4.84n/a6
Mar ’24€5.40
€6.36
+17.8%
12.0%€7.37€4.94€5.956
Feb ’24€5.00
€6.17
+23.5%
11.4%€7.03€4.82€5.356
Jan ’24€4.48
€5.53
+23.4%
16.8%€6.63€4.31€5.256
Dec ’23€4.48
€5.53
+23.4%
16.8%€6.63€4.31€5.306
Nov ’23€3.78
€5.48
+45.1%
17.6%€6.70€4.40€4.806

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.

Discover undervalued companies

China Life Insurance

HK$824.2b

Operates as a life insurance company in the People’s Republic of China.

CLF

HK$5.95

7D

0%

1Y

-22.2%

China Life Insurance

HK$1.1t

Operates as a life insurance company in the People’s Republic of China.

CHL

HK$1.90

7D

-3.6%

1Y

46.8%

AXA

€72.3b

Through its subsidiaries, provides insurance, asset management, and banking services worldwide.

AXA

€34.20

7D

-0.6%

1Y

20.7%